by Kharrazian Institute | Jul 30, 2026 | Blog, Diabetes and Dysglycemia
Most practitioners order an HbA1c and read 5.8 as normal. The standard reference range calls it fine. The patient gains another twelve pounds, reports unrelenting fatigue, and returns six months later at 6.2. By that point, insulin resistance has been progressing for...
by Kharrazian Institute | Jul 29, 2026 | Blog, Diabetes and Dysglycemia
Most practitioners order a fasting glucose and call it done. If the number is normal, blood sugar comes off the differential. But fasting glucose is a single snapshot of a system that operates in constant flux — and the patients sitting in your office with unresolved...
by Kharrazian Institute | Jul 28, 2026 | Autoimmunity, Blog
Most practitioners who work with autoimmune patients are missing the same thing: a sequenced evaluation process that accounts for clustering, tissue-specific antibodies, and gut-immune dynamics simultaneously. A standard ANA panel and a symptom checklist are not an...
by Kharrazian Institute | Jul 24, 2026 | Autoimmunity, Blog
A common practitioner mistake: removing gluten from an autoimmune patient’s diet, watching them improve initially, then losing the clinical thread when symptoms return weeks later. The assumption is compliance failure. The more likely explanation is...
by Kharrazian Institute | Jul 21, 2026 | Autoimmunity, Blog
Most practitioners ordering an ANA panel believe they are assessing for autoimmunity. They are not. They are checking one narrow immunological window while the actual mechanisms driving tissue destruction continue undetected. The clinical gap between standard...
